Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury

Por Regan, Christopher P., Adam, Paul J., Madsen, Cort S., Owens, Gary K.
Publicado em 2000

Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects

Por Regan, Christopher P., Li, Wei, Boucher, Diane M., Spatz, Stephen, Su, Michael S., Kuida, Keisuke
Publicado em 2002

Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells

Por Taylor, Joan M., Mack, Christopher P., Nolan, Kate, Regan, Christopher P., Owens, Gary K., Parsons, J. Thomas
Publicado em 2001

Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry

Por Lagrutta, Armando, Regan, Christopher P., Zeng, Haoyu, Imredy, John P., Koeplinger, Kenneth, Morissette, Pierre, Liu, Liping, Wollenberg, Gordon, Brynczka, Christopher, Lebrón, José, DeGeorge, Joseph, Sannajust, Frederick
Publicado no Sci Rep (2017)

Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist

Por Bell, Ian M., Gallicchio, Steven N., Wood, Michael R., Quigley, Amy G., Stump, Craig A., Zartman, C. Blair, Fay, John F., Li, Chi-Chung, Lynch, Joseph J., Moore, Eric L., Mosser, Scott D., Prueksaritanont, Thomayant, Regan, Christopher P., Roller, Shane, Salvatore, Christopher A., Kane, Stefanie A., Vacca, Joseph P., Selnick, Harold G.
Publicado em 2010